Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP)

Definition / Introduction

Background / Rationale (Why it was launched)

• Branded medicines in India are sold at significantly higher prices than their unbranded generic equivalents, despite being therapeutically identical.
• Out-of-pocket (OOP) expenditure on medicines is one of the major causes of catastrophic health spending and poverty in India.
• The scheme addresses this inequity by making generic medicines available at prices 50-90% lower than branded counterparts.

Implementation Agency

• Pharmaceuticals & Medical Devices Bureau of India (PMBI) - formerly known as Bureau of Pharma PSUs of India (BPPI) - is the nodal implementation agency.
• It was established in December 2008 under the Department of Pharmaceuticals, registered as an independent society under the Societies Registration Act, 1860.
• PMBI coordinates procurement, supply, distribution, and marketing of generic medicines through PMBJKs.

Vision and Mission

Objectives

1. To make quality generic medicines available at affordable prices to all, especially the poor
2. To reduce out-of-pocket expenditure on medicines and decrease financial burden on families
3. To extend access to essential medicines in rural, remote, and underserved areas
4. To promote generic drugs and dispel the myth that branded = better quality
5. To generate employment by supporting individuals (women, SC/ST, disabled, entrepreneurs) to open Kendras
6. To achieve Universal Health Coverage (UHC) goals

Jan Aushadhi Kendra (PMBJK) - Key Features

• Dedicated pharmacy outlets selling only generic medicines
• Present in all 726+ districts of India; target of 25,000 PMBJKs by March 2026
• Grew from 1,080 outlets (2016-17) to over 9,998+ Kendras (as of recent data)
• Product basket: Over 1,800 generic medicines + 285 surgical items across all therapeutic categories
• All medicines tested at NABL-accredited laboratories for quality assurance
• Medicines sold at 50-90% cheaper prices than branded counterparts

Financial Support & Incentives for Kendra Owners

• Government provides financial assistance up to Rs. 2.5 lakhs for opening a Kendra
• Special incentives for women entrepreneurs, disabled persons, SC/ST candidates
• Monthly performance incentives up to Rs. 15,000/- for effective operations

Significance in Community Medicine / Public Health

• Directly addresses social determinants of health - affordability as a barrier to treatment
• Reduces impoverishment due to illness (catastrophic health expenditure)
• Supports National Health Policy 2017 goal of reducing OOP expenditure
• Contributes to SDG 3 - Good Health and Well-being
• Particularly beneficial for patients with chronic non-communicable diseases (diabetes, hypertension, cancer) who need long-term drug therapy

Challenges

• Low awareness among general public (only ~38% aware in community surveys)
• Misconception that generic medicines are inferior in quality
• Inadequate geographic coverage in remote areas
• Low motivation among doctors to prescribe generic drugs by name
• Supply chain gaps and stock-out issues at Kendras

Conclusion (as K. Park would frame it)

Exam Tip: For a 5-mark answer in your university exam, include: Introduction + Background (1 mark) → Objectives (1 mark) → Features of PMBJK/Implementation (1.5 marks) → Public Health Significance (1 mark) → Challenges/Conclusion (0.5 mark). Use bold keywords, short crisp headings, and a 2-column table for vision/mission - examiners love structured clarity in the K. Park style.